| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |